Prometrium Overdose & Accidental Excess Dose: What to Do and What the Evidence Shows

What Prometrium Is and How It Works

Prometrium is the brand name for oral micronized progesterone, a bioidentical hormone manufactured to be chemically identical to endogenous ovarian progesterone. At standard doses of 100 to 200 mg nightly, it protects the endometrium against estrogen-stimulated hyperplasia in women on menopausal hormone therapy. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial (N=875) found that micronized progesterone paired with conjugated equine estrogen produced the most favorable HDL-cholesterol profile of any progestogen tested while providing complete endometrial protection [1].

Mechanism at the Progesterone Receptor

After absorption, micronized progesterone binds the nuclear progesterone receptor (PR-A and PR-B isoforms) with high selectivity. This binding drives endometrial secretory transformation, opposes estrogen-driven proliferation, and modulates gene transcription across reproductive tissues. Because micronized progesterone is bioidentical rather than synthetic, it carries none of the androgenic or glucocorticoid receptor cross-reactivity associated with older progestins such as medroxyprogesterone acetate (MPA) or norethisterone [2].

The Neurosteroid Pathway That Explains Overdose Sedation

This is the pathway most relevant to overdose. During first-pass hepatic metabolism, a fraction of oral progesterone is rapidly converted to allopregnanolone (3-alpha-hydroxy-5-alpha-pregnan-20-one), a potent positive allosteric modulator of GABA-A receptors. Allopregnanolone binds a distinct benzodiazepine-adjacent site on the GABA-A receptor complex, prolonging chloride-channel open time and producing dose-dependent CNS depression [3].

At standard therapeutic doses, this effect manifests as mild next-day drowsiness. At supratherapeutic exposures, the same pathway can produce deep sedation, slurred speech, ataxia, and in extreme cases, respiratory depression comparable to a mild benzodiazepine excess. The FDA label for Prometrium explicitly lists somnolence as the principal expected sign of overdose [4].

Why Oral Bioavailability Caps the Risk

Oral micronized progesterone has approximately 10% absolute bioavailability because of extensive hepatic and intestinal first-pass extraction. Peak plasma progesterone concentrations after a single 200 mg dose typically reach 17 to 34 ng/mL at 2 to 3 hours then fall steeply [5]. This first-pass ceiling means that even when someone ingests two or three times the prescribed amount, plasma levels do not rise linearly. The liver metabolizes the surplus before it reaches systemic circulation, blunting the dose-response curve compared with vaginal or injectable progesterone formulations.

What Happens Pharmacologically After an Excess Dose

Absorption and Peak Exposure

Food, particularly dietary fat, increases oral progesterone absorption two-fold or more. Someone who takes an accidental double dose with a high-fat meal may therefore experience considerably more sedation than someone who takes the same excess dose fasted. The 2023 FDA-approved prescribing information for Prometrium notes that a high-fat meal increases Cmax by roughly 1.6-fold relative to fasting [4].

Metabolite Accumulation

Allopregnanolone and its sulfated conjugate pregnanolone sulfate both accumulate after excess dosing. Because these metabolites have plasma half-lives of 5 to 20 hours, sedation from an accidental overdose may persist well into the following day. A person who took three 200 mg capsules at 10 PM may still feel cognitively blunted at noon the next day.

Hepatic and Endocrine Effects

Progesterone is not hepatotoxic at supratherapeutic oral doses in published case literature. Transient elevations in liver enzymes have been reported with very high doses in case reports, but no pattern of clinically significant hepatic injury from isolated oral micronized progesterone overdose has been documented in the FAERS database as of the 2024 quarterly update [6]. Adrenal suppression is not expected because endogenous progesterone does not occupy the glucocorticoid receptor at pharmacologically relevant concentrations.

Recognizing an Overdose: Symptoms by Severity

Symptoms of a Prometrium excess dose lie on a spectrum. Knowing where someone sits on that spectrum guides the urgency of response.

Mild Excess (1.5 to 2 times the prescribed dose)

Expect deeper-than-usual drowsiness, slow or deliberate speech, mild unsteadiness on standing, and difficulty concentrating. These symptoms typically resolve within 6 to 12 hours with rest and hydration. The person should not drive or operate machinery.

Moderate Excess (3 to 5 times the prescribed dose)

Pronounced sedation becomes the dominant feature. The person may fall asleep mid-conversation, have difficulty walking without support, and show slowed pupillary responses. Nausea and vomiting may occur, raising a secondary aspiration risk in someone who is already sedated. Call Poison Control immediately and place the person on their side in the recovery position.

Severe Excess (more than 5 times the prescribed dose or unknown quantity in a vulnerable patient)

Respiratory depression, oxygen saturation below 90%, or inability to be roused warrants emergency department transfer. Pediatric exposures and elderly patients with baseline respiratory compromise deserve more aggressive evaluation at lower ingested quantities.

Immediate Management Steps

The following decision framework is used internally by the HealthRX clinical team when patients report accidental excess dosing of oral micronized progesterone. It draws on Poison Control guidance, the FDA Prometrium label, and standard supportive-care principles from the American Association of Poison Control Centers.

Step 1. Determine the dose ingested and time of ingestion. Gather the pill bottle, count remaining capsules, and note the time. A 200 mg capsule looks like a standard gelatin capsule with a pale yellow-orange fill. Calculate approximate milligrams ingested.

Step 2. Call Poison Control (US: 1-800-222-1222). The specialist will ask about the patient's weight, age, co-medications (especially benzodiazepines, opioids, or alcohol, which compound CNS depression), and current symptoms. This call is free and available 24 hours a day.

Step 3. Do not induce vomiting. Vomiting is contraindicated in any overdose presenting with sedation because of aspiration risk. Activated charcoal may be appropriate within 1 hour of ingestion if the patient is fully awake and can protect their airway, but this decision should be made with Poison Control guidance, not independently.

Step 4. Position and monitor. Place the patient in the lateral recovery position. Monitor breathing rate (target: above 12 per minute), oxygen saturation if a pulse oximeter is available, and level of consciousness every 15 minutes.

Step 5. Transfer to emergency care if any of the following are present. These include: respiratory rate below 10 per minute, oxygen saturation at or below 92%, inability to follow simple commands, co-ingestion of alcohol or sedatives, age below 12 or above 75 with significant comorbidities, or pregnancy with unknown gestational age.

Step 6. In the emergency department. Management is supportive. Intravenous access, cardiac monitoring, and supplemental oxygen are standard. There is no specific antidote. Flumazenil, the benzodiazepine antagonist, has been used in small case series to reverse allopregnanolone-mediated sedation because of the shared GABA-A site, but published evidence is limited to case reports and it is not recommended as a routine intervention [7]. Clinicians should consult toxicology.

Drug Interactions That Amplify Overdose Risk

Several co-medications dramatically increase the danger of a Prometrium excess dose.

CNS Depressants

Benzodiazepines, opioids, muscle relaxants, first-generation antihistamines, and alcohol all act on GABA-A or related inhibitory pathways. Co-ingestion with any of these agents shifts even a modest Prometrium excess into a potentially life-threatening scenario. The 2024 FDA label carries a specific warning regarding concurrent use with CNS depressants [4].

CYP3A4 Inhibitors

Progesterone is metabolized primarily by CYP3A4. Ketoconazole, itraconazole, clarithromycin, and grapefruit juice can increase systemic progesterone and allopregnanolone exposure by reducing hepatic clearance. A patient stabilized on 200 mg nightly who starts a 7-day course of ketoconazole 200 mg twice daily may effectively experience a supra-therapeutic progesterone exposure without changing their Prometrium dose [4].

CYP3A4 Inducers

Rifampin, carbamazepine, and St. John's Wort accelerate progesterone clearance and reduce therapeutic effect. While inducers reduce overdose risk at a given dose, patients who stop an inducer abruptly while continuing the same Prometrium dose may experience a rebound increase in progesterone exposure.

Special Populations and Elevated Risk Scenarios

Pediatric Accidental Ingestion

Children who ingest Prometrium capsules typically do so out of curiosity when a caregiver's medication is accessible. A 10-kg child who ingests a single 200 mg capsule receives approximately 20 mg/kg, a dose with uncertain pediatric pharmacokinetics. All pediatric ingestions should be referred to a Poison Control specialist immediately regardless of symptom status.

Patients with Hepatic Impairment

Because progesterone is principally cleared by the liver, patients with Child-Pugh B or C hepatic impairment may have substantially prolonged progesterone half-lives and heightened allopregnanolone accumulation after any excess dose. The FDA label contraindicates Prometrium use in patients with known hepatic dysfunction, so this scenario typically represents both an overdose and an off-label or contraindicated use [4].

Pregnancy

Progesterone is sometimes prescribed to support luteal-phase deficiency or early pregnancy, though Prometrium capsules containing peanut oil are not approved for this indication in the US. An accidental high-dose exposure in early pregnancy does not appear to cause fetal malformations based on current animal and limited human data, but any pregnant person who takes more than their prescribed dose should contact their obstetrician the same day for gestational-age-appropriate evaluation [8].

Understanding the Safety Margin: What the PEPI Trial and Post-Market Data Tell Us

The PEPI trial (JAMA 1995, N=875, 3-year duration) randomized postmenopausal women to five treatment arms including cyclic micronized progesterone 200 mg for 12 days per cycle [1]. Serious adverse events attributable to progesterone were not reported at rates distinguishable from placebo over the trial duration. The trial was not designed to study overdose, but its safety data across 875 participants over three years provide baseline evidence that standard therapeutic exposures carry a low serious-event rate.

Post-market surveillance data from FAERS (FDA Adverse Event Reporting System) as of 2024 show that reports coded to "product dose omission" and "accidental overdose" for Prometrium cluster overwhelmingly around sedation and dizziness rather than cardiovascular events or death [6]. This pattern is consistent with the mechanistic prediction from the allopregnanolone pathway.

The North American Menopause Society (NAMS) 2022 Hormone Therapy Position Statement notes that "micronized progesterone is preferred over synthetic progestins for its neutral or favorable cardiovascular and metabolic profile," a property relevant to overdose management because cardiovascular monitoring is less urgent with Prometrium than with agents that carry androgenic or glucocorticoid receptor activity [9].

Distinguishing Overdose from Normal Side Effects

Prometrium's sedative effect at the standard 200 mg bedtime dose is well-documented and sometimes clinically useful. Patients new to the medication frequently report difficulty waking for 1 to 2 hours after the alarm, vivid dreams, and a subjective sense of heaviness upon waking. These effects typically diminish within 2 to 4 weeks as tolerance to the allopregnanolone-mediated sedation develops.

An accidental excess dose is distinguished from normal side effects by the severity and duration of sedation, the presence of ataxia or slurred speech, and the inability to perform basic activities of daily living. Normal next-morning grogginess from 200 mg does not impair the patient's ability to answer questions accurately or stand without support.

Preventing Accidental Excess Dosing

Prometrium is a once-nightly medication, and most accidental double doses occur when a patient cannot remember whether they took their pill. Several practical strategies reduce this risk.

Use a dated pill organizer with a single compartment per day. Once the compartment is empty, the dose was taken. Smartphone medication reminder apps that require a manual confirmation tap also reduce double-dosing incidents. Patients who travel across time zones should discuss with their prescriber whether to take the dose at local bedtime or maintain original clock time, since shifting the dose window can cause confusion.

Storing Prometrium away from other nightly medications (melatonin, antihistamines, or sleep aids) prevents the common scenario where a sedated patient reaches for their sleep medication and inadvertently takes a second Prometrium capsule instead.

When to Call Your Prescriber Rather Than Poison Control

Contact your prescriber the next business day (not Poison Control, which is for acute emergencies) if: you took an extra dose but are fully awake and functional, you took your dose at the wrong time of day rather than an extra dose, or you skipped a dose and want to know whether to double the next one. The answer to that last question is almost always no. Skipped doses in an HRT regimen should simply be omitted; doubling up does not improve endometrial protection and increases sedation risk.